Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ciprofloxacin Versus Levofloxacin and Rate of Breakthrough Infections in Hematopoietic Stem Cell Transplant Patients

NCT03850379 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT03850379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03850379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ciprofloxacin Versus Levofloxacin and Rate of Breakthrough Infections in Hematopoietic Stem Cell Transplant Patients
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Completed
Start date
March 14, 2018
Completion date
August 30, 2024
Enrollment
308 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prophylaxis, stem cell transplant complications